Loading company…
Orbital Therapeutics develops RNA-based medicines for vaccines, immunomodulation, protein replacement and regenerative medicine.
Orbital Therapeutics develops RNA-based medicines by combining RNA delivery methods, data science and automation. Its research focuses on vaccines, immunomodulation, protein replacement and regenerative medicine. Founded in 2022, the company is based in the US and was co-founded by Giuseppe Ciaramella, Kristina Burow and Carol Suh. In April 2023, it raised USD 270 million in Series A funding led by ARCH Venture Partners, with participation from Andreessen Horowitz, Newpath Partners and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in